Jaebeom Cho

505 total citations
15 papers, 387 citations indexed

About

Jaebeom Cho is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jaebeom Cho has authored 15 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Jaebeom Cho's work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (3 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Jaebeom Cho is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (3 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Jaebeom Cho collaborates with scholars based in South Korea, United Kingdom and Ethiopia. Jaebeom Cho's co-authors include Ho‐Young Lee, Hye‐Young Min, HJ Lee, Seung Yeob Hyun, Young Kee Shin, Byung Seok Kim, Hye‐Jin Boo, Ho Jin Lee, Yu‐Jin Jung and Yeonseok Chung and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Cancer Research.

In The Last Decade

Jaebeom Cho

14 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaebeom Cho South Korea 11 172 155 153 74 43 15 387
Haley L. Peters United States 10 174 1.0× 112 0.7× 175 1.1× 81 1.1× 49 1.1× 11 381
Wenna Jiang China 12 201 1.2× 124 0.8× 169 1.1× 124 1.7× 56 1.3× 23 400
Zhengfa Mao China 11 265 1.5× 103 0.7× 155 1.0× 95 1.3× 23 0.5× 22 426
Zhifa Cao China 7 191 1.1× 76 0.5× 89 0.6× 103 1.4× 70 1.6× 11 380
Shao‐Lan Qin China 13 269 1.6× 93 0.6× 179 1.2× 140 1.9× 53 1.2× 26 482
Julian Burks United States 11 289 1.7× 262 1.7× 186 1.2× 60 0.8× 21 0.5× 16 493
Yongsheng Li China 8 238 1.4× 85 0.5× 84 0.5× 151 2.0× 56 1.3× 14 385
Mara Mazzoni Italy 10 196 1.1× 62 0.4× 117 0.8× 58 0.8× 59 1.4× 14 330
Snahlata Singh India 11 246 1.4× 103 0.7× 205 1.3× 148 2.0× 50 1.2× 14 468
Brooke Ancrile United States 3 166 1.0× 116 0.7× 224 1.5× 79 1.1× 47 1.1× 7 399

Countries citing papers authored by Jaebeom Cho

Since Specialization
Citations

This map shows the geographic impact of Jaebeom Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaebeom Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaebeom Cho more than expected).

Fields of papers citing papers by Jaebeom Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaebeom Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaebeom Cho. The network helps show where Jaebeom Cho may publish in the future.

Co-authorship network of co-authors of Jaebeom Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Jaebeom Cho. A scholar is included among the top collaborators of Jaebeom Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaebeom Cho. Jaebeom Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cho, Jaebeom. (2025). Understanding Tumor Dormancy: from Experimental Models to Mechanisms and Therapeutic Strategies. Biomolecules & Therapeutics. 33(5). 770–784.
2.
Cho, Jaebeom, Hye‐Young Min, & Ho‐Young Lee. (2023). Isolation of slow-cycling cancer cells from lung patient-derived xenograft using carboxyfluorescein-succinimidyl ester retention-mediated cell sorting. STAR Protocols. 4(2). 102167–102167. 1 indexed citations
3.
Min, Hye‐Young, Jaebeom Cho, Hye‐Jin Boo, et al.. (2022). S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3‐mediated programmed death‐ligand 1 expression in colorectal cancer. Clinical and Translational Medicine. 12(7). e986–e986. 15 indexed citations
4.
Hyun, Seung Yeob, Hye‐Young Min, Ho Jin Lee, et al.. (2022). Ninjurin1 drives lung tumor formation and progression by potentiating Wnt/β-Catenin signaling through Frizzled2-LRP6 assembly. Journal of Experimental & Clinical Cancer Research. 41(1). 133–133. 17 indexed citations
5.
Cho, Jaebeom, Hye‐Young Min, Ho Jin Lee, et al.. (2021). RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse. Journal of Clinical Investigation. 131(1). 39 indexed citations
6.
Le, Huong Thuy, Ho Jin Lee, Jaebeom Cho, et al.. (2021). Insulin-Like Growth Factor Binding Protein-3 Exerts Its Anti-Metastatic Effect in Aerodigestive Tract Cancers by Disrupting the Protein Stability of Vimentin. Cancers. 13(5). 1041–1041. 14 indexed citations
7.
Cho, Yong‐Hee, Eun Ji Ro, Jaebeom Cho, et al.. (2020). Small molecule-induced simultaneous destabilization of β-catenin and RAS is an effective molecular strategy to suppress stemness of colorectal cancer cells. Cell Communication and Signaling. 18(1). 38–38. 9 indexed citations
8.
Cho, Jaebeom, Hye‐Young Min, Xuan Wei, et al.. (2020). The ATF6-EGF Pathway Mediates the Awakening of Slow-Cycling Chemoresistant Cells and Tumor Recurrence by Stimulating Tumor Angiogenesis. Cancers. 12(7). 1772–1772. 22 indexed citations
9.
Cho, Jaebeom, HJ Lee, Su Jung Hwang, et al.. (2020). The Interplay between Slow-Cycling, Chemoresistant Cancer Cells and Fibroblasts Creates a Proinflammatory Niche for Tumor Progression. Cancer Research. 80(11). 2257–2272. 28 indexed citations
10.
Min, Hye‐Young, Seung Yeob Hyun, Hye‐Jin Boo, et al.. (2020). Potent Anticancer Effect of the Natural Steroidal Saponin Gracillin Is Produced by Inhibiting Glycolysis and Oxidative Phosphorylation-Mediated Bioenergetics. Cancers. 12(4). 913–913. 23 indexed citations
11.
Park, Jieun, Yong‐Hee Cho, Sang Gyu Lee, et al.. (2019). A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer. Scientific Reports. 9(1). 25 indexed citations
12.
Min, Hye‐Young, Su-Chan Lee, Jong Kyu Woo, et al.. (2016). Essential Role of DNA Methyltransferase 1–mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors. Clinical Cancer Research. 23(5). 1299–1311. 21 indexed citations
13.
Kim, Il‐Kyu, Byung Seok Kim, Eun‐Ah Bae, et al.. (2015). Glucocorticoid-induced tumor necrosis factor receptor–related protein co-stimulation facilitates tumor regression by inducing IL-9–producing helper T cells. Nature Medicine. 21(9). 1010–1017. 135 indexed citations
14.
Min, Hye‐Young, Jisun Lee, HJ Lee, et al.. (2015). Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer. Molecular Cancer. 14(1). 113–113. 37 indexed citations
15.
Cho, Jaebeom, et al.. (2013). Taeyoung Submerged-type Membrane Filtration for Advanced Drinking Water Treatment. Journal of the Korean geoenvironmental society. 14(4). 15–27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026